LOXL1 rs3825942: Understanding Your Genetic Risk for Glaucoma
The rs3825942 variant is a common genetic change in the LOXL1 gene associated with an increased risk of developing exfoliation syndrome and exfoliation glaucoma. It is a missense variant that alters the protein structure, potentially affecting how ocular tissues maintain their extracellular matrix.
What each genotype means
Baseline risk profile
This genotype represents the homozygous state for the G allele of the rs1048662 variant in the LOXL1 gene. Research indicates that common variants in LOXL1 are associated with susceptibility to exfoliation syndrome and related glaucoma, though the specific risk contribution of this variant is considered limited and may vary significantly by ancestral background.
This genotype is common globally, though its frequency varies significantly across different ancestral populations.
Baseline risk profile
This heterozygous genotype contains one G allele and one A allele of the rs1048662 variant. While LOXL1 variants are known to influence the extracellular matrix in ocular tissues, the clinical impact of this specific heterozygous combination remains limited and is not considered a diagnostic indicator for exfoliation glaucoma.
This genotype is frequently observed in diverse populations, reflecting the common nature of the G and A alleles at this locus.
Baseline risk profile
This genotype represents the homozygous state for the A allele of the rs1048662 variant. Current evidence suggests that while LOXL1 gene variants are linked to exfoliation syndrome, the association for this specific variant is limited, and it should not be used to predict individual clinical outcomes or disease risk.
This genotype is found across multiple ancestral groups, consistent with the reported allele frequencies for this common variant.
What is the rs3825942 Variant?
The rs3825942 variant is a single nucleotide polymorphism (SNP) located within the LOXL1 gene. In genetic terms, this is a missense variant, meaning the change in the DNA sequence results in a different amino acid being incorporated into the protein. Specifically, this variant causes a substitution of glycine for aspartic acid at position 153 (Gly153Asp) in the LOXL1 protein. Because this variant is found in a high percentage of the general population, it is considered a common genetic marker. Researchers study this specific site because it is located in a region of the gene that is critical for the proper function of the resulting enzyme. By analyzing this SNP, scientists aim to understand how subtle changes in protein structure can lead to the accumulation of abnormal material in the eye, which is a hallmark of exfoliation syndrome.
The Role of the LOXL1 Gene
The LOXL1 gene provides instructions for making the lysyl oxidase-like 1 protein. This protein plays a vital role in the extracellular matrix, which is the structural framework that supports cells and tissues throughout the body. In the eye, LOXL1 is essential for the formation and maintenance of elastic fibers, particularly in the tissues of the anterior segment, such as the lens capsule and the ciliary body. When the LOXL1 protein does not function correctly, it can lead to the production of abnormal, protein-rich fibrillar material. This material can accumulate in the eye, potentially blocking the drainage of fluid and increasing intraocular pressure. This process is the primary mechanism behind exfoliation syndrome, a condition that significantly increases the risk of developing a specific type of glaucoma known as exfoliation glaucoma.
Research and Evidence Strength
The association between LOXL1 variants and exfoliation syndrome is well-documented in scientific literature, though the evidence is considered complex. Multiple genome-wide association studies have identified rs3825942 as a significant risk factor for exfoliation glaucoma across various ancestral groups. However, the strength of this association can vary significantly depending on the population being studied. For instance, while the variant is strongly linked to disease risk in many cohorts, many individuals who carry the risk alleles never develop the condition. This suggests that the variant is not a single, definitive cause of the disease but rather a susceptibility factor. Other genetic, environmental, and lifestyle factors likely play a major role in whether an individual actually develops symptoms. Because of this, the clinical utility of testing for this variant remains limited for individual diagnostic purposes.
Population Frequency
The rs3825942 variant is remarkably common across diverse ancestral groups, with allele frequencies typically ranging between 15% and 45%. Because the risk allele is so prevalent in the general population—even among those who do not have glaucoma—it is clear that carrying this variant does not guarantee the development of the disease. Researchers have noted that the high frequency of these variants in healthy individuals highlights the complexity of the condition's inheritance. In some populations, the risk alleles are actually the most common versions of the gene, suggesting that they may have been ancestral forms. The wide distribution of this variant across different ethnicities underscores the importance of considering broader genetic and environmental contexts when evaluating individual risk for eye-related conditions.
What You Can Do With This Information
If you have received information about your LOXL1 genotype, it is important to understand that this is not a medical diagnosis. Genetic variants like rs3825942 are only one piece of a much larger puzzle regarding your eye health. You cannot use this information to predict with certainty whether you will develop glaucoma. The most effective way to manage your risk is to maintain regular, comprehensive eye examinations with an ophthalmologist or optometrist. These professionals can monitor your intraocular pressure and the health of your optic nerve, which are the most reliable indicators of glaucoma risk. If you have a family history of glaucoma or are concerned about your results, discuss them with your eye care provider. They can provide personalized guidance based on your clinical history rather than relying on genetic data alone.
How common is this variant?
The rs3825942 variant is common across multiple ancestral groups, with allele frequencies typically ranging from 15% to 45%.
Frequently asked questions
Does having the risk allele mean I will get glaucoma?
No, having the risk allele does not mean you will develop glaucoma. Many people with the risk variant never develop the condition, as it is only one of many factors that contribute to eye health.
Should I get tested for LOXL1 variants?
Genetic testing for LOXL1 is generally not recommended for the general public. Regular eye exams are the standard and most effective way to monitor for glaucoma and maintain eye health.
What is the difference between exfoliation syndrome and glaucoma?
Exfoliation syndrome is a condition where abnormal material builds up in the eye. Glaucoma is a group of eye conditions that damage the optic nerve, and exfoliation syndrome is a known risk factor for developing a specific type of glaucoma.
Can I change my risk if I have this variant?
You cannot change your genetic code, but you can manage your eye health through regular screenings. Early detection by an eye care professional is the best way to manage risks associated with glaucoma.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1048662?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LOXL1
Common missense variant (Arg141Leu) in LOXL1 historically associated with pseudoexfoliation syndrome; recent evidence suggests these variants may be proxies for other causative regulatory variants.
Missense variant in LOXL1 associated with pseudoexfoliation syndrome and glaucoma.
Exonic missense variant (p.Gly153Asp) in LOXL1 conferring major risk for pseudoexfoliation syndrome and secondary glaucoma.
Missense variant in LOXL1 strongly associated with pseudoexfoliation syndrome and secondary glaucoma.
Common missense variant (Arg141Leu) in LOXL1; strongly associated with exfoliation syndrome and glaucoma.
A missense variant (p.Gly153Asp) in LOXL1 strongly associated with pseudoexfoliation syndrome and secondary open-angle glaucoma.